MATERIALS AND METHODS A total of 28 patients (Table 1) admitted to hospital because of
acute asthma were included in this study, and their informed written consent was obtained …

The aim of the study was to determine the maximum effective dose of nebulized ipratropium
bromide, 0· 5 or 1· 0 mg, in the treatment of acute severe attacks of asthma. Thirty-two …

To evaluate the role of inhaled ipratropium bromide in acute asthma, a double-blind study of
384 emergency department patients compared the effect of the combination of ipratropium …

In a recent study, it was suggested that the preservatives in ipratropium bromide nebulizer
solution may cause a paradoxic bronchoconstrictor response in 20 percent or more of …

The efficacy of ipratropium and salbutamol was determined in 117 patients with acute
asthma who presented to an emergency department to determine whether the order of …

The role of ipratropium bromide as adjunct therapy to β-agonists in acute asthma is
uncertain. We therefore decided to compare the use of 3 mg of salbutamol sulfate alone vs 3 …

In a double-blind randomized trial, 40 patients with acute severe asthma were given either
nebulized salbutamol, 5 mg, or salbutamol, 5 mg mixed with ipratropium bromide 500 μg, on …

Twenty-four consecutive patients admitted to hospital with severe acute asthma were
studied. Eleven were given 10 mg salbutamol by nebulizer followed 2 hours later by 500 μg …

Study objective: To determine the effect of adding the nebulized anticholinergic drug
ipratropium bromide to standard therapy compared with standard therapy alone for acute …

Background: Routine addition of ipratropium bromide to β-agonist therapy in acute asthma is
of uncertain benefit. Objective: This study was carried out to evaluate:(1) whether nebulized …